Literature DB >> 2988389

Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.

J K Nicholson, J S McDougal, H W Jaffe, T J Spira, M S Kennedy, B M Jones, W W Darrow, M Morgan, M Hubbard.   

Abstract

Immunologic and serologic studies were done in 120 homosexual men who reportedly had no symptoms related to the acquired immunodeficiency syndrome. Forty-nine men (41%) had antibody to the retrovirus human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV), and 37 (31%) had an abnormal T-cell subset ratio and other immunologic abnormalities. These abnormalities were almost exclusively confined to men seropositive for the retrovirus. Multivariate statistical analysis showed that exposure to HTLV-III/LAV was the single best predictor of T-cell (and other) immunologic abnormalities. Sexual practice, particularly receptive anal intercourse, predicted exposure to HTLV-III/LAV but was not independently related to T-cell abnormalities. The association of other microbial serologic findings with HTLV-III/LAV seropositivity or T-cell changes was a coincidental function of sexual activity. Immunologic abnormalities in asymptomatic homosexual men are mostly related to exposure to HTLV-III/LAV.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988389     DOI: 10.7326/0003-4819-103-1-37

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  18 in total

1.  Prognostic significance of cytotoxic T cells in individuals infected with human immunodeficiency virus.

Authors:  C Mihailov; A Lamour; V Beaudré-Bellein; N Jézequel; M Garré; D Mottier; G Guillet; P Youinou
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

2.  Autoproliferation in HIV-1-infected patients undergoing active HIV-1-specific immunotherapy.

Authors:  R J Trauger; W Giermakowska; S Wormsley; J Turner; F C Jensen; D J Carlo
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

Review 3.  The natural history of human T lymphotropic virus-III infection: the cause of AIDS.

Authors:  M Melbye
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

Review 4.  The clinical prognosis of HIV-1 infection: a review of 32 follow-up studies.

Authors:  G S Cooper; D J Jeffers
Journal:  J Gen Intern Med       Date:  1988 Nov-Dec       Impact factor: 5.128

5.  Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice.

Authors:  Kaori Sango; Aviva Joseph; Mahesh Patel; Kristin Osiecki; Monica Dutta; Harris Goldstein
Journal:  AIDS Res Hum Retroviruses       Date:  2010-07       Impact factor: 2.205

Review 6.  Sexual transmission of HIV: routes, efficiency, cofactors and prevention. A survey of the literature.

Authors:  M van der Graaf; R Diepersloot
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

7.  Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.

Authors:  M G Brook; J A McDonald; P Karayiannis; L Caruso; G Forster; J R Harris; H C Thomas
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

8.  Immunoglobulin level in donor blood reactive for antibodies to human immunodeficiency virus.

Authors:  N Nath; C Wunderlich; F W Darr; D K Douglas; R Y Dodd
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

9.  The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men.

Authors:  M T Schechter; W J Boyko; B Douglas; B Willoughby; A McLeod; M Maynard; K J Craib; M O'Shaughnessy
Journal:  CMAJ       Date:  1986-12-15       Impact factor: 8.262

10.  Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle.

Authors:  A C Collier; R C Barnes; H H Handsfield
Journal:  Am J Public Health       Date:  1986-05       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.